Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation
Condition(s):Hepatocellular CarcinomaLast Updated:July 21, 2016Unknown status
Hide Studies Not Open or Pending
Condition(s):Hepatocellular CarcinomaLast Updated:July 21, 2016Unknown status
Condition(s):Systemic Lupus Erythematosus (SLE)Last Updated:March 25, 2024Recruiting
Condition(s):Pancreatic CancerLast Updated:September 12, 2019Completed
Condition(s):Mycobacterium AviumLast Updated:December 15, 2016Completed
Condition(s):LeukemiaLast Updated:June 7, 2018Unknown status
Condition(s):Hepatocellular CarcinomaLast Updated:January 18, 2018Unknown status
Condition(s):Cortisol Excess; Stress, Psychological; Anxiety; Epigenetic Disorder; Natural Killer Cell Cytokine Production; Environmental ExposureLast Updated:April 7, 2022Not yet recruiting
Condition(s):Relapsed/Refractory AML; AML, Adult; MDS; Refractory Myelodysplastic SyndromesLast Updated:September 5, 2023Recruiting
Condition(s):Colorectal Cancer Stage IVLast Updated:November 7, 2022Completed
Condition(s):Lymphoma, Non-Hodgkin; B-cell Acute Lymphoblastic Leukemia; Large B-cell Lymphoma; Mantle Cell Lymphoma; Indolent Lymphoma; Waldenstrom Macroglobulinemia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Aggressive Lymphoma; Large-cell LymphomaLast Updated:March 21, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.